| Price | 11.00p on 16-01-2026 at 19:30:04 |
|---|---|
| Change | 0.00p 0% |
| Buy | 12.00p |
| Sell | 10.00p |
| Last Trade: | Buy 10,000.00 at 12.10p |
| Day's Volume: | 40,391 |
| Last Close: | 12.10p |
| Open: | 11.80p |
| ISIN: | GB00B02LCQ05 |
| Day's Range | 11.00p - 12.10p |
| 52wk Range: | 5.25p - 12.10p |
| Market Capitalisation: | £743.11m |
| VWAP: | 11.64914p |
| Shares in Issue: | 6.14b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Allergy Thera. (AGY) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 10,000 | 12.10p | Suspected BUY Trade |
16:35:26 - 16-Jan-26 |
| Buy* | 5,000 | 11.80p | Suspected BUY Trade |
14:00:18 - 16-Jan-26 |
| Buy* | 3,800 | 11.80p | Suspected BUY Trade |
11:00:06 - 16-Jan-26 |
| Buy* | 3,716 | 11.30p | Ordinary |
10:40:10 - 16-Jan-26 |
| Sell* | 4,643 | 10.77p | Ordinary |
09:55:44 - 16-Jan-26 |
| Buy* | 4,899 | 12.00p | Suspected BUY Trade |
09:00:15 - 16-Jan-26 |
| Sell* | 3,333 | 10.77p | Ordinary |
08:00:13 - 16-Jan-26 |
| Buy* | 5,000 | 11.80p | Suspected BUY Trade |
08:00:12 - 16-Jan-26 |
| Buy* | 8,000 | 12.10p | Suspected BUY Trade |
16:35:18 - 15-Jan-26 |
| Buy* | 6,000 | 11.80p | Suspected BUY Trade |
14:00:16 - 15-Jan-26 |
Allergy Thera. (AGY) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th Jan 2026 7:00 am | RNS | Notice of 2025 Annual General Meeting |
| 29th Dec 2025 1:07 pm | RNS | Results of General Meeting |
| 29th Dec 2025 1:07 pm | RNS | Results of General Meeting |
| 16th Dec 2025 7:00 am | RNS | Grassmuno® marketing authorisation in Germany |
| 12th Dec 2025 7:00 am | RNS | Authority for allotment of New Shares |
| 11th Dec 2025 7:00 am | RNS | Prelim Results and publication of Annual Report |
| 9th Dec 2025 7:00 am | RNS | Primary Safety Endpoint Met in PROTECT trial |
| 6th Nov 2025 7:22 am | RNS | Company to Evaluate Dual Listing on HKEX |
| 30th Oct 2025 7:00 am | RNS | G308 Phase III Year 2 Patient Screening Starts |
| 29th Oct 2025 7:00 am | RNS | Warrant Exercise and Paydown of Debt |
